stents
Interviews and expert commentary tagged “stents” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?
Gregg Stone REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GREGG STONE, Columbia University, New York New light has been thrown on the u
Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI
Laura Mauri Raymond Gibbons REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida LAURA MAURI, Brigham and Woman’s Hospit
Patients with High Restenosis Risk Benefit More from Drug Eluting Stents
Raul Moreno REFERENCE: Abstract 3103, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria RAUL MORENO, University Hospital La Paz, Madrid Results from a large meta analysis s
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
Joseph Muhlestein Sidney Smith Joost Daemen Drug Eluting Stents: More Deaths in Real World Use REFERENCE: American Heart Association Scientific Sessions, Chicago, November 12-15, 2006. Abstract: 2225
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
Oscar Marroquin Sanjay Kaul Joseph Sweeny Maximo Rivero-Ayerza Repeat Revascularization With Drug Eluting versus Bare Metal Stents REFERENCE: American Heart Association Scientific Sessions, Chicago, N
Audio Journal of Cardiovascular Medicine: Sirolimus-Eluting Better Than Uncoated Stents for Primary Angioplasty
CHRISTIAN SPAULDING, Cochin Hospital, Paris REFERENCE: N Engl J Med 2006;355:1093, 1105,1169 Two leading articles in the same edition of the New England Journal of Medicine have investigated the use o
Audio Journal of Cardiovascular Medicine: September 8th 2006
Christoph Kaiser John Cleland BASKET Study Shows Bare Metal Stents Can Be Better REFERENCE: 4825 “Clinical Trial Update I” Session Christoph Kaiser, University of Basel Bare metal stents m
Late-Stent Throbosis Risk after Clopidogrel Withdrawal: Greater in Drug Eluting Stents
Matthias Pfisterer, University Hospital Basel American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 422-11. Lancet 2005:366:921 Clopidogrel therapy may
Sirolimus Eluting Stent Superior in Meta Analysis
Antonio Abbate, Medical College of Virginia, Richmond American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 2912-74 Even though drug eluting stents have
ENDEAVOR or Cypher? Comparison of Drug Eluting Stents
The ABT578-eluting ENDEAVOR stent has been compared head-to-head with sirolimus-eluting Cypher. Duke University’s David Kandzari told us more. [audio:https://www.audiomedica.com/podcasting/aha20
Drug-eluting Stents: No Benefit in Vein Grafts
Drug-eluting stents should not be the favoured option for treating saphenous vein graft lesions according conclusions from a registry analysis presented to the American Heart Association conference by
Drug-Coated Balloon for In-Stent Restenosis: First Experience
Bruno Scheller Bruno Scheller, Universitatsklinikum des Saarlandes, Homburg Saar A future option for treating in-stent restenosis is the idea of coating a balloon with an anti-proliferative drug and i
Endeavor: Alternative Drug-Eluting Stent?
Jean Fajadet The ESC heard the latest on the Endeavor stent, which elutes the sirolimus analogue ABT-578. Jean Fajadet from Toulouse told Audio Medica about the findings from ENDEAVOR II study of arou
Drug-eluting Stents: Cost-Benefit Targeting?
Matthias Pfisterer Drug-eluting stents and their additional benefit to low-risk patients were investigated in a cost-effectiveness analysis presented to the Stockholm cardiology meeting by Matthias Pf